Royalty Pharma : Vorasidenib Transaction Call Transcript
REFINITIV STREETEVENTS EDITED TRANSCRIPT RPRX.OQ - Royalty Pharma PLC To Host Investor Call ...
Stay updated with breaking news from Michael Difiore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
REFINITIV STREETEVENTS EDITED TRANSCRIPT RPRX.OQ - Royalty Pharma PLC To Host Investor Call ...
Kodiak Sciences Inc. misses on earnings expectations. Reported EPS is $-1.13 EPS, expectations were $-0.86. Kodiak Sciences Inc.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Mineralys Therapeutics Third Quarter 2023 Conference Call. [Operator Instructions].
Operator: Hello and welcome to the Halozyme Third Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise.
Daniel Skovronsky, Lilly’s chief scientific and medical officer, said in an interview that the Lilly Institute for Genetic Medicine along Fort Point Channel will ultimately accommodate 500 Lilly scientists and researchers.